Best Nephrectomy doctors: TOP 148 doctors

Dr. Gokhan Yilmaz is an experienced general surgeon with nearly 20 years in medical practice. He is known for his skill in complex surgical procedures. He earned his Master’s Degree from Istanbul University Çapa Faculty of Medicine. He completed his Doctorate in General Surgery at Okmeydanı Training and Research Hospital, one of Turkey’s leading institutions.

Dr. Yilmaz worked as a General Surgery Specialist at Zonguldak Atatürk State Hospital for 5 years. He then served at Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital for 3 years. In these roles, he managed a wide range of surgical cases. He also served as an Assistant Professor at Istanbul Medipol University, where he trained future surgeons and contributed to research.

Dr. Yilmaz is currently part of the General Surgery Department at Medipol University Pendik Hospital. He provides advanced treatments and high-quality patient care. His experience in state hospitals, research centers, and universities highlights his dedication to surgical excellence and patient safety.

Dr. Jose Horacio Cano Cervantes is a Medical Surgeon who graduated with honors from the Autonomous University of Chiapas, Mexico. He is a certified specialist in Nephrology by the National Autonomous University of Mexico.

He received advanced training in Transplant Nephrology at the National Institute of Medical Sciences and Nutrition "Salvador Zubirán." He also trained at the Jiménez Díaz Foundation in Madrid, Spain. Dr. Cano Cervantes is completing a Master’s Degree in Health Sciences at the National Polytechnic Institute.

He is an active member of the Mexican Transplant Society. He is recognized for his expertise and dedication to nephrology and transplant medicine.

Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.

Education and Career

2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

Medicine Department of Internal Medicine

2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

Memberships in Scientific Organizations

ASCO

ESMO

TTOD 

AVOD 

Publications

In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

Awards Received

EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

Speeches Delivered at National Congresses, Conferences, and Symposia:

Courses, Meetings, and Certificates

ESMO certified Medical Oncologist since 2019

Education and Specialization

• Bachelor’s & Master’s Degree: Akdeniz University Faculty of Medicine, 1990 /1996
• Ph.D. / Medical Specialization: Urology, Akdeniz University, 1997/2002
• Associate Professor / Professor: Urology, Harran University, 2012/ 2013
• Professor: Urology, Istanbul Gelişim University, Faculty of Health Sciences, 2019/ 2023

Professional Experience

• Research Assistant: Akdeniz University Faculty of Medicine, Department of Urology, Antalya (1997/ 2002)
• Urology Specialist: Akdeniz University Faculty of Medicine, Department of Urology, Antalya (March 2002 / October 2002)
• Lecturer: Harran University Faculty of Medicine, Department of Urology, Şanlıurfa (2003/ 2006)
• Assistant Professor: Harran University Faculty of Medicine, Department of Urology, Şanlıurfa (2006 / 2010)
• Associate Professor: Harran University Faculty of Medicine, Department of Urology, Şanlıurfa (2012 /2013)
• Associate Professor: Ministry of Health Antalya Training and Research Hospital, Urology Clinic, Antalya (2013 /2018)
• Associate Professor: Memorial Antalya Hospital, Urology Clinic, Antalya (2018 /2019)
• Professor: Memorial Antalya Hospital, Urology Clinic, Antalya & Istanbul Gelişim University, Faculty of Health Sciences (2019/ 2023)
• Professor: Medical Park Antalya Hospital Complex (2023 / Present)

International Experience

• Berlin University, Charité Hospital – Fellowship in Urology (February 1 - March 31, 2006, Berlin, Germany)
• Akdeniz University Faculty of Medicine, Urology Clinic – Postgraduate Education in Laparoscopic Surgery by Endourology Association (May 1 - June 12, 2008, Antalya, Turkey)

Memberships in Scientific Organizations

• Turkish Urology Association
• Turkish Andrology Association
• Turkish Endourology Association
• Turkish Medical Association
• European Association of Urology
• Endourological Society
• Urological Surgery Association
• Eurasian Urooncology Association
• Turkish Pediatric Urology Association
•  
• TÜYK Competency Certificate
• "Recent Advances in Laparoscopic Urology" & "Urodynamics and Neuro-Uropharmacology" (October 8, 2000, Izmir)
• IRCAD Advanced Laparoscopic Urology Course Certificate (February 13-15, 2008)
• Laparoscopic Training Program Certificate (Endourology Association, 2008, Antalya)
• Experimental Animal Usage Certificate (January 26 - February 4, 2009)

Dr. Sılay is an experienced pediatric urologist practicing in Turkey.

Specialty

Assoc. Prof. Selçuk Sılay specializes in robotic surgery for urology conditions in children.

Dr. Selçuk Sılay has provided over:

• 300 pediatric laparoscopic surgeries
• 100 pediatric robotic surgeries
• 300 closed kidney stone surgeries in children.

Work experience

• Since 2018 – Urologist in Memorial Bahçelievler Hospital and Memorial Ataşehir Hospital
• 2017-2018 – Pediatric urology robotic surgery specialist in Mehmet Akif Ersoy Training and Research Hospital
• 2016-2018 – Head of Pediatric Urology Department in Istanbul Medeniyet University Göztepe Training and Research Hospital
• 2011-2016 – Head of Pediatric Urology Department at the Bezmialem Foundation University
• 2009 – Urology Specialist in Diyarbakir Bismil State Hospital
• 2006-2007 – Urology and Robotic Surgery Specialist.

Education

• 1997-2003 – Ankara University Medical School – Degree in general medicine
• 2003 – Baylor College of Medicine (USA) – Training in urology
• 2004-2009 – Istanbul Şişli Hamidiye Etfal Education And Research Hospital – Training in urology
• 2006-2007 – Baylor College of Medicine (USA) – Internship in urology
• 2014-2015 – Texas Children's Hospital (USA) – Pediatric Urology Robotic Surgery Training (USA).

Awards

• 2016 Young Academician of the Year Award by the 24th National Urology Congress in Cyprus
• 2018 Crystal Matula Award as European Academician of the Year.

Scientific activity

Prof. Selçuk Sılay provides research in robotic surgery in children. Has written over 80 articles.

Membership in organizations

• The Turkish Society of Pediatric Urology
• The European Association of Urology
• The European Society for Paediatric Urology
• The Turkish Association of Urology.

Specialties

Kidney and urinary tract endoscopic stone crushing treatment

Endoscopic Prostate and Bladder Surgery (TUR Method)

Diagnosis and surgery of testicular diseases

Diagnosis and treatment of infertility in men (Varicocele surgeries)

Diagnosis and treatment of sexual dysfunctions

Treatment of urinary incontinence in women

Treatment of nocturnal incontinence in children

Treatment of undescended testicle in children

Circumcision

Experience

1995-1999 Bilecik State Hospital Urology Clinic

1999-2002 Kocaeli Gölcük State Hospital Urology Clinic

2002-2006 Sakarya Karasu State Hospital Urology Clinic and Chief Physician

2006-2012 Kocaeli State Hospital Urology Clinic and Chief Physician

2012-2015 Kocaeli State Hospital Urology Clinic

2015-2018 Kocaeli Public Hospitals Secretary General

2018-2021 Kocaeli Provincial Health Director

2021-2023 Kocaeli Darıca Farabi Training and Research Hospital Urology Clinic

2023- 2024 Kocaeli Gölcük Necati Çelik State Hospital Urology Clinic

2024 Private Darıca Büyük Anadolu Hospital

Education

Uludag University Faculty of Medicine (graduation) 1988

Selcuk University Faculty of Medicine (specialization) 1994

1982-1988 Uludağ University Faculty of Medicine

1990 -1994 Selcuk University Faculty of Medicine, Department of Urology (Specialization)

Scientific Publications

Acar A., Sert I. Ü., Gürbüz R., Ergüney Ş: Submucosal methotrexate applications in inoperable bladder tumors.  S.Ü.T.F. Journal. 1993; 9(1):39-41

Acar A., Sert İ.Ü., Gürbüz R., Arslan E.M., Ergüney Ş. , : Bladder wall and prostate

Translated with DeepL.com (free version)

Education/Academic Experience

Apr 1995 – Oct 2001                Medical School of Aristotle University of Thessaloniki, Greece

Mar 2007                                   IELTS Certificate (Overall Band Score 7.5)

Feb 2011                                    CCST in Urology, Aristotle University of Thessaloniki, Greece

June 2012                                  Fellow of the European Board of Urology (FEBU)

Sept 2014                                  Fellow in Andrology/Reconstructive Surgery (Mr Giulio Garaffa,         UCLH / Mid-Essex)

Apr 2016                                   Fellow of the Royal College of Surgeons of England (FRCS Eng)

Oct 2018                                   Honorary Senior Lecturer St Andrews University

Sep 2019                                   Urology ChM Tutor in Andrology and Minimally Invasive Surgery (MIMS) University of Edinburgh

Aug 2020                                  European Union Expert Panel Member of in vitro Medical Devices (EU EXPAMED)

Current and Previous appointments

Current appointment

May 2022- Present         Consultant Urologist German Oncology Centre, Limassol, Cyprus

Previous appointments

Nov16- May 2021       Consultant Urological Surgeon Victoria/ Queen Margaret Hospital Fife, Scotland.

Nov 2012 - Oct 2016      Consultant Urologist Broomfield Hospital, Mid-Essex Hospitals Trust 

Jan 2011 - Oct 2012      Urology Clinical Research Fellow, Spelialist Registrar Level), Bristol Royal Infirmary, United Bristol Hospitals Trust

Dec 2009 -Dec 2010      Urology Resident G. Gennimatas Hospital, Aristotle University of Thessaloniki

Duties

• Performing routine and major Penile / Urethral Reconstruction as well as Core Urology procedures twice weekly at Victoria and Queen Margaret Hospitals (Green light prostatectomy, Urolift Service lead, Prostate template biopsies, General urology)

Consultant Urologist providing and supervising the services of andrology and urethral reconstruction surgery. Also covering a general urology one stop outpatient clinics three times per week (Victoria and Queen Margaret Hospitals).

Participation in once weekly local cancer and once monthly specialist male uro-genital reconstruction MDT meetings (Honorary contract at the Western General Hospital, Edinburgh) as well as grand ward rounds.

Undergraduate student trainer and member of examiners panel at St Andrews University, Scotland.

Participation in 1:9 on call Urology Consultant rota.

Research

• Victoria Hospital, Kirkcaldy (NHS Fife) lead investigator. A prospective, multicentre study with subgroup randomisation into MRI-U/S image fusion guided prostate biopsies and routine transrectal U/S guided biopsies.  (MULTIPROS Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A pragmatic multicentre randomised superiority trial of open urethroplasty versus endoscopic urethrotomy. (OPEN Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A Multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones. (TISU
• Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Randomised Controlled Trial of the Use of Drug Therapy in the Management of Symptomatic Ureteric Stones in Hospitalised Patients. (SUSPEND Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Prospective Single Arm Intervention Trial Evaluating Focal Therapy using High Intensity Focused Ultrasound (Sonablate 500) for Localised Prostate Cancer. (HIFU INDEX Study)
•  
• Bristol Royal Infirmary sub-investigator, A Randomised Controlled Trial to Determine the Effect of Decapeptyl on Reduction of Prostate Volume Pre-Radiotherapy Compared with Standard Therapy (Zoladex). (EDVART Study)

Teaching Experience

Fife Simulation BPH Course Fascilitator (Scottish Urology Training Programme, Queen Margaret Hospital, Dumfermline Fife)

Urology Simulation boot camp Faculty member (St James's University Hospital, Leeds)

General Practitioner Urology Training Programme Fascilitator (ScotGem)

Objective Structured Clinical Examination (OSCE) assessor (St Andrews University Medical School)

Teaching (case-based discussions) and trainee supervision in theatres (East Anglia / East of   Scotland Deaneries trainees)

FY1 Doctors Urology teaching Bristol Royal Infirmary (University Bristol Hospitals Trust)

Undergraduate teaching of medical students in General Hospital of the city of Drama, Greece

Anatomy, Physiology and First Aid to Undergraduate nursing students

In his professional career, Dr. Sarıer began working as a urology specialist at Özel Antalya Yaşam Hospital from 2005 to 2008, and then served at Gümüşsuyu Asker Hospital between 2008 and 2009. Since 2009, he has been employed at Medical Park Antalya Hospital, where he received the title of associate professor in 2020. Additionally, he served as a faculty member in the Department of Urology at Altınbaş University Faculty of Medicine from 2016 to 2017, and has been continuing his academic career as a faculty member in the Department of Urology at İstinye University Faculty of Medicine since 2021.

Education:

1997 – 2003    Hacettepe University

2004 – 2009     Ankara Dışkapı Training and Research Hospital

2016 – 2019     Afyon Kocatepe University

Experience:

2022 – Still       Lokman Hekim Akay Hospital

2019 – 2022     Private Meddem Hospital

2018 – 2019      Afyon Kocatepe University

2015 – 2018      Afyon Kocatepe University

2012 – 2015      Bozok University Faculty of Medicine

2010 – 2012     Ankara Dışkapı Training and Research Hospital

2009 – 2010      TSK Rehabilitation and Care Center Presidency

2004 – 2009     Ankara Dışkapı Training and Research Hospital

HEESEOK KANGDepartment of Obstetrics

• Education/Academic career
• Graduated from Yonsei University College of Medicine
• Internship, Samsung Medical Center
• Residency and M.D., Obstetrics and Gynecology, Samsung Medical Center
• Head of Department, Obstetrics and Gynecology, Gyeonggi Provincial Medical Center Pocheon Hospital
• Clinical Instructor, Obstetrics and Gynecology, Samsung Medical Center
• Head of Department, Obstetrics and Gynecology I, Good Morning Hospital
• Head of Department, Obstetrics and Gynecology, Daerim St. Mary’s Hospital
• Director of Obstetrics and Gynecology & Academic Affairs of Medical Department , Hismedi Hospital
• Head of Department, Heryoujae Women’s Hospital
• Current)Adjunct Professor, Obstetrics and Gynecology, Samsung Medical Center
• Current)Expert for NAVER KnowledgeiN
• Professional memberships
• Award for Exemplary Safety Management, Samsung Medical Center, 2002
• Award for Excellence in QI Poster, Samsung Medical Center, 2007
• Outstanding Thesis Award, Korean Society of Gynecologic Oncology and Colposcopy, 2008
•  
• [Thesis]
•  
• 1. Single port access laparoscopic adnexal surgery. Kim TJ, Lee YY, Kim MJ, Kim CJ, Kang H, Choi CH, Lee JW, Kim BG, Bae DS. J Minim Invasive Gynecol. 2009 SepOct;16(5):6125.
• 2. The prognostic significance of the SUVmax (maximum standardized uptake value for F18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results. Lee YY, Choi CH, Kim CJ, Kang H, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG. Gynecol Oncol. 2009 Oct;115(1):658. Epub 2009 Jul 15.
• 3. Singleport access laparoscopicassisted vaginal hysterectomy: a novel method with a wound retractor and a glove. Lee YY, Kim TJ, Kim CJ, Kang H, Choi CH, Lee JW, Kim BG, Lee JH, Bae DS. J Minim Invasive Gynecol. 2009 JulAug;16(4):4503. Epub 2009 May 31.
• 4. Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: results of a singleinstitutional phase II study. Kang H, Kim TJ, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG. Gynecol Oncol. 2009 Aug;114(2):2104. Epub 2009 May 14.
• 5. MR Imaging in Endometrial Carcinoma as a Diagnostic Tool for the Prediction of Myometrial Invasion and Lymph Node Metastasis. Ryoo UN, Choi CH, Yoon JY, Noh SK, Kang H, Kim WY, Kim BH, Kim TJ, Lee JW, Lee JH, Kim BG, Bae DS. Cancer Res Treat. 2007 Dec;39(4):16570. Epub 2007 Dec 31.
• 6. Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation. Choi CH, Kang H, Kim WY, Kim TJ, Lee JW, Huh SJ, Lee JH, Kim BG, Bae DS. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):199204.
• 7. Lowgrade endometrial stromal sarcoma: a single center's experience with 22 cases. Kim WY, Lee JW, Choi CH, Kang H, Kim TJ, Kim BG, Lee JH, Bae DS. Int J Gynecol Cancer. 2008 SepOct;18(5):10849.
• 8. Outcome and reproductive function after cumulative highdose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Kang H, Kim TJ, Kim WY, Choi CH, Lee JW, Kim BG, Bae DS. Gynecol Oncol. 2008 Oct;111(1):10610.
• 9. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy. Choi CH, Song SY, Choi JJ, Park YA, Kang H, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS. BMC Cancer. 2008 Oct 11;8:295.
• 10. Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer Kang H, Kim TJ, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG. JKMS. 2009 Oct. (in press)
• 11. Ritodrine hydrochloride 단독 투여와 magnesium sulfate와의 병합 투여의 조기진통 억제효과 및 안정성에 대한 비교 김영아, 강희석, 양순하, 김종화 대한산부인과학회 2002;45:1991.
• 12. Experience of Surgical Treatment for Adnexal Lesions in Adolescent Patients 이은주, 강희석, 윤병구, 배덕수, 최두석 대한산부내시경 2002;14:79
• 13. 태아간 수혈증후군이 의심되는 단일 융모막성 쌍태임신에서 발견된 일측 쌍생아의 선천성 뇌실주위 백질 연화증 1예 강희석, 양순하, 오성희, 강병희, 노정래, 김종화 대한산부인과학회 2002:45:841
• 14. 자궁근종 치료에서 modified LAM 기법의 타당성 조사 연구 이은주, 김태중, 지현영, 김하정, 김철중, 이유영, 강희석, 최철훈, 이정원, 김병기, 배덕수 대한산부내시경 2008;20:35
• 15. 위암, 유방암, 난소암의 원발성 중복암이 있었던 환자의 증례보고 최현진, 최철훈, 김태중, 강희석, 이은주, 이정원, 김병기, 이제호, 배덕수 대한산부인과학회 2008;51:1519
• 16. Factors associated with complicationsand conversion to laparotomy in women undergoing laparoscopically assistedvaginal hysterectomy. Song T, Kim TJ, Kang H, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS. Acta Obstet Gynecol Scand. 2012 May;91(5):6204.
• 17. A review of the technique and complicationsfrom 2,012 cases of laparoscopically assisted vaginal hysterectomy at a singleinstitution. Song T, Kim TJ, Kang H, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS. Aust N Z J Obstet Gynaecol. 2011 Jun;51(3):23943.
• 18. The use of misoprostol beforehysteroscopic surgery in nonpregnant premenopausal women: a randomizedcomparison of sublingual, oral and vaginal administrations. Lee YY, Kim TJ, Kang H, Choi CH, Lee JW, Kim BG, Bae DS. Hum Reprod. 2010 Aug;25(8):19428.
• 19. Prognostic significance of pSTAT3 inpatients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy. Choi CH, Song SY, Kang H, Lee YY, Kim CJ, Lee JW, Kim TJ, Kim BG, Lee JH, Bae DS. J Obstet Gynaecol Res. 2010 Apr;36(2):30410.
• 20. Outcome and reproductive function after cumulative highdose combination chemotherapy with bleomycin, etoposideand cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Kang H, Kim TJ, Kim WY, Choi CH, Lee JW, Kim BG, Bae DS.

Education and Expertise

• 1997 – 2003 – ULUDAĞ UNIVERSITY FACULTY OF MEDICINE
• 2003 – 2008 – IZMIR ATATURK TRAINING AND RESEARCH HOSPITAL INTERNAL MEDICINE DEPARTMENT
• 2009 – 2012 – EGE UNIVERSITY FACULTY OF MEDICINE DIVISION OF NEPHROLOGY
• 2015 – HEALTH SCIENCES UNIVERSITY IZMIR BOZYAKA EAH ASSOCIATE PROFESSOR
• 2021 – UNIVERSITY OF HEALTH SCIENCES, IZMIR FACULTY OF MEDICINE, PROFESSORSHIP

Diseases

• Kidney Transplant
• Diabetic Kidney Disease
• Glomerulonephritis
• Hypertension
• Chronic Renal Failure

Treatment Methods

• Kidney Transplantation, Preparation and Follow-up
• Diabetic Kidney Disease Treatment
• Glomerulonephritis Treatment
• Hemodialysis
• Hypertension Treatment
• Peritoneal (Abdominal) Dialysis

Experience

• Izmir Tepecik Training and Research Hospital Internal Medicine Specialist Position
• Izmir Bozyaka Training and Research Hospital Nephrology Clinic Specialist Position
• Izmir Bozyaka Education and Research Hospital Nephrology Clinic Administrative Responsibility
• Health Sciences University, Izmir Faculty of Medicine, Internal Medicine Lecturer

Professional Memberships

• Turkish Medical Association
• Turkish Society of Nephrology
• Turkish Internal Medicine Association
• ERA EDTA vest

Assoc. Prof. Dr. Cenk Acar completed his medical education at Ankara University Faculty of Medicine and his urology residency at Gazi University Faculty of Medicine, Department of Urology. He worked as an assistant professor at Pamukkale University Faculty of Medicine, Department of Urology between June 2009 and November 2012. Between May 2012 and November 2012, he worked as a fellow in robotic and laparoscopic surgery in urologic cancers for 6 months in the Urology Department of “The Netherland Cancer Institute-AVL hospital”. He started to work at Acıbadem Ankara Hospital in November 2012. In September 2014, he completed the necessary academic qualifications and received the title of “Associate Professor”. After working in a private hospital in Ankara between 2015-2020, he continued his services in his private practice in Ankara until 2020 when he started Hisar Intercontinental Hospital.

In 2015, he was the chairman of the organizing committee of the first course on ‘Fluorescence Imaging in Urological Surgery’ in the field of urology in Turkey. In the following years, he chaired many urology and multidisciplinary courses on ICG fluorescence imaging under the umbrella of Urology Associations. In 2017, for the first time in Turkey, he started to apply Bipolar Prostate Enucleation in benign prostate enlargement in his clinic. Later, he started to use his increasing experience in surgeries such as HOLEP and THUFLEP.

In his career, Dr. Acar, who is especially interested in Urological Cancers, Urinary System Stones, HOLEP, THUFLEP, Endourology, and Robotic and Laparoscopic Urological Surgeries, has carried out many successful operations. He has performed over 500 urological cancer surgeries, over 250 HOLEP surgeries, countless endoscopic stone surgeries, and numerous robotic and laparoscopic surgeries.

FIELDS OF MEDICAL INTEREST

• Localized Prostate Cancer Treatments
• Quality of Life in Urological Cancers
• Sentinel Lymph Node Dissections in Prostate Cancer
• Intraoperative Fluorescence Imaging Techniques in Robotic and Laparoscopic Urological Surgery
• Prostate Enucleations in BPH (HOLEP, BIPOLEP, THULEP)
• Urinary System Stone Disease

Clinical experience

Residency in Urology Bellvitge University Hospital (2007/2012)

Urologist Bellvitge University Hospital. (May 2012/November 2021)

Head of Andrology Department, Bellvitge University Hospital. (February 2015/November 2021)

Head of Andrology Department Hospital Clínic of Barcelona (December 2021 present)

Director of the Institute of Andrology and Sexology. Quironsalud Group. (October 2015 January 2018).

Head of Andrology Department Teknon Medical Centre (November 2017 present)

Editor of the International Journal of Andrology (July 2016 present)

Clinical practice in the field of Reproductive Medicine and Sexology Memorial Sloan Kettering Cancer Center. New York City (USA) (March 2016 May 2016)

Education

Doctor of Medicine (Universitat de Barcelona) degree with honors, 2006

Specialization in Urology Hospital Universitari de Bellvitge, 2006 2012

Associate Professor of Clinical Andrology (Universitat Autònoma de Barcelona), 2014

Participant of the European Board of Urology (Bruselas UEMS), 2012

Member of the European Committee of Sexual Medicine (Estambul UEMS), 2014

Dr. Javier Centeno obtained his Doctorate in Medicine and Surgery from the University of Barcelona in 1988 and completed his specialization in General and Gastrointestinal Surgery at the Hospital de Mutua de Terrassa between 1989 and 1993.

Afterwards, Dr. Centeno completed additional training in the colorectal surgery department at the Mayo Clinic de Rochester, Minnesota (USA). Since 1993, Dr. Centeno has been a leading specialist in the surgery department at the Teknon Medical Center.

Clinical and scientific work:

Co-organizer of the Seminar on Endorectal Ultrasound Diagnostics. Advances in Colon, Rectum and Anus Surgery. Barcelona. March 1995.

"Visiting Surgeon" in the Department of Colorectal Surgery, Cleveland Clinic Florida, Fort Lauderdale, Florida, USA, February 1996.

Advanced Course in Laparoscopic Colorectal Surgery. ICARD. EITS, Strasbourg. November 2002.

Postgraduate student, associate professor of the Department of Urogynecoproctological Physiotherapy.

School of Nursing and Physiotherapy, University of Blanquerna. Ramon Llull University. Barcelona. 2003 2015

Accreditation by ERAS-Society (Sweden) in 2016.

Member of scientific communities:

Asociación Española de Cirujanos

· Societat Catalana de Cirurgia

· American Society of Colon and Rectal Surgeons y de la University of Minnesota Alumni Association.

Dr. Ismael Avila Iniguez is a certified General Surgeon and Urologist. He trained at the Autonomous University of Guadalajara and UNAM. He has performed over 3,000 urological and oncological surgeries. Dr. Avila helped establish organ transplant units in Baja California and has improved cancer care in the region.

He is certified by the Mexican Councils of General Surgery and Urology. Dr. Avila has served as General Director and active surgeon at the General Hospital of Mexicali. He is a member of the Mexican Societies of Urology and Oncology. He has received several awards for his clinical and academic work.

Dr. Georg Schatzl is a urologist and andrologist. He specializes in men’s health, including erectile dysfunction, infertility, prostate diseases, and urinary tract disorders. He has performed thousands of procedures. Dr. Schatzl is known for his skill in both clinical and surgical urology.

He is an Extraordinary University Professor and a Fellow of the European Board of Urology (FEBU). Dr. Schatzl has published nearly 100 articles in international journals. His work has an impact factor of over 521 and a high h-index. He has given more than 500 presentations at national and international conferences. He also reviews articles for leading urology journals.

Dr. Schatzl has received awards such as the Mauermayerpreis (2003) and the Pfizer Prostate Award (1998). He leads the Prostate Work Group of the Austrian Board of Urology. He also has experience in quality assurance and medical management.

Dr. Jacob Ben-chaim is a Pediatric Urologist at the Sourasky Medical Center with experience in chemical immunology, laparoscopic pyeloplasty, and ECFMG certification. He is certified by the Technion Institute, Haifa, Israel, The Johns Hopkins Hospital and University, Baltimore MD, USA, and Tel Aviv University, Sackler School of Medicine. He is a member of the Israel Medical Association, Israel Urological Association, American Urological Association, and Chairman of the Pediatric Urology Union. He has received awards for best Pediatric Urology study and holds an ECFMG Certificate valid indefinitely.

Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.

Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.